Use of atropine early during dobutamine stress echocardiography  by Owen, A.N. et al.
Corn/~ wn (1) lmago qunllty and seventy 01 Induced dyssynergy have 
Iho rnosl stgnrlrcanl rmpact on IOA 12) Standardlzatlon 01 Image drsplay and 
RC results in lmprovod IOA on DSE mtorprotatron 
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Dobulamw strers whowdq~aphy @SE) commonty u5ea 3 mmute (mm) 
stages rk?spto requmng up to 10 mtn to reach steaey Mate. Pnor F&ckes 
have demonstrated the utrkty of protortgod stage duratron. but OSE re already 
a tcme con+#ummg last We dev&ped a novel accelerated DSE (ADSE) 
protocol in whrch a a!ngle, high c4xm (4Q mcgAig/mm) mfueron ot dobulamme 
1s adrnmlatered tar up to 10 mtnutes. or uflkl target HR (85% prectrcted ma*) 
r* reached It target HR was nol reach& atropme (0 2 mcgmun, 1 0 mq 
max) wae added. Feas~brlrty. satety. and efficacy ot AOSE were assessed 
m patients (pts) wtth a high pretest Irhehhood ot CAD. HA. BP. ECG and 
symptoms were asses-sed at 1 mm mtervah throughout he mtusloo AOSE 
was admmr5tered to 47 curtee pts (46 males. 1 ternale) with a mean 
age 01 m c 11 years. Patmnls had an average 01 4 4 I 1 3 cardtac nsh 
tactorg and 49% had known CAD 
Res&?s.ADSEmcreasedtheHR(68 t2710133t39bpm p- 001) 
wtth an avftrage test duratron ot 11 4 T 3 1 mm Target HR was reached in 
19 0122 (86%) pts r-rot on beta-btockers (86) but m onty 11 0125 (44%) pts 
on BB (p = 0 001) Symptoms mcluded palptatrons (21%). dizzmess (12%). 
chest pam @%). headaches (6%). or nausea (6%) There were no eprsodes 
01 suslarned VT, VF or serious adverse event% 
Concksrons AOSE wrth a conbnuous t?rgb dose rs Castble and sale m 
pts wilh known or suspectefl CAD and achrt?vt?s target HA wrth a shorter 
duratron Further mvestrgatron lnrth an angmgmphrc golcl standard writ be 
necessary to dotermme the sensrhrrty of AOSE 
i-i !&ss Echocatdiigraphy 
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T~drtronal endpornts (ENOW for lermmatmq dobulamme atropme stress 
cchocardrography (OASE) have beer- the use ot a predeftned maxrmal dose 
01 dobutamme (DOB) and atropme (AT) or attamment ot 85% ot maxrmurn age 
pre&cted heart rate (MPHR). a value derived from exercrse stress testrng 
Whether these conslrtute optimum ENOPT for DASE 1s unclear 
loo consecr&ve posrtrve DASE sludres performed with u-iual ENDPT 
(85”. MPHR. 40 to 50 mcgkgimm 008 + maxrmum 2 mg AT, etiensrve wall 
mOtron abr?ormallty hypotensroF. or anhythrnta) were evaluated to assess 
HR. “.MPHR. wall motron score !mdex. DOB and AT doses when posrt!v~ly ot 
the study (wwrsenmg ot watt matron by -1 grade) tlrst developed and al peak 
dose. Hypothetrcal ENOPT for peak HR and %MPHR were then apptred to 
these 130 DASE to detennme oplrmum OASE posrtwrty tor rschemta. Al t*rst 
poatrvrly. dose ot DOB was 28.8 : 10 9 mcgikgimtn (range 5 lo 50) and AT 
0.20 z 0.47 mg (range 0 lo 2) vs DOB 36 5 t 6 1 mcqkgmrn and AT 0 5 : 
0 7 mg at study completron 
p oool"* lloanal15bpm ‘p- 0ocr”s:o~.MPHR 
There was no srgnrhcant drfference m DASE posttw~ty uttltzmd ENDPT 
of HR 120 bpm vs. 75O. MPHR At trad!t!onal ENDPT of 85% MPHR or 
maxtmum DOB and AT dose. dragnoss was changed ‘ram sngle veSSel 
CAD to mulbvessel disease rn only 6 studies 
In conclusion. optrmum ENDPT tor DASE rnclude HR 120 bpm or 75’0 
MPHR rn addltlon to rschemra. hypolenslon. or arrhyihmra. 
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A significant percent of pts undergoing dobutamrne stress echocardrography 
(DSE) will fail to reach target heart rate with dobutamme alone and wltl require 
atropme (ATR). We have prevrously detinnd cr’!enx wht.1 predict farlure to 
reach ‘,RS?b PMAX by 12 min (end ot Stage 4 - 40 mcgkg/mrn) of standard 
0% pr01ocoI Those cntrma are Ago 50 ya OR HR at hasekne 60 m 
OR HR 81 ena of 6 mm (Stage 2 . 20 mcg&pmmt f$pb PMAX f*r pt$ 
moetmg theso cntefba were randomly asrgned to euher a standard tbktue~l 
votocot (In whfch 0 25 mg AYR 1s given q t mm atter eompletron of Stage 4 
to a total do% at 1 mg) (Group IA. n P 25) or early atropma protocol (GIN 
18. n E 29) m whtch 0.25 mq 4TR was @van at the bgmnmg al Stage 3 anq 
of Stage 4. wrth an addrttonat 0 2% mg &TR grven al 19 and 14 rntn rt needed 
Thea8 patrente were compared additronally wrth 30 pts who were pr@ctert 
lo achieve -85% PMAX and rececvad a standard McNarll protacot (Grm 
21 Tlme to p=aah I+R was ehortsr m Qroup it3 man m Group 1A (12 0 I o 3 
VI 13 f 1 0 3 mm. p = 0 001). although atoll onger than m Group 2 (to 4 I 
0 5 mm, p = 0 01) In addftion. Gro*~p 1B and Group 2 had simfbr rates et 
decline m HR attef etu@y tonnmatlon. reachmg BB 1 1% and 68 r 2% PMAX 
respectively at 6 mm pact HR In Group 1A remamed htgher. kxqar. fallmg 
to only 72 * 2% at 6 mm Post (p = 0 01) Graph PcteW @how3 stage 61 wtvch 
pts reached peak HR 
-‘Cfroup IA 
Conclusrons- 1) Eartv atropme use srgntfrcantly shortens OSE protocal 2) 
HR returns to baselme values qurcker wrlh early atroptne admmrslratron 
I 
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Kmetrc exe- rncroases the cardrac outpui and pulmonary blwd now 
and consequently pulmonary artery sy3otrc pressure (PASP) However the 
upper physioiogrc ltrnrt 01 PASP response lo ererase has not been completely 
addressed The obtectrve 01 thrs sludy was lo define the spectrum 01 PASP 
dunnq elercm 
Melhods Frcm 1994 lo 1997. 102 subfects (mean ago 36 9 I 15 6. range 
?l to 80 years) (56 men, 46 womer,) underwent a standardrzed semrrecum- 
bent echo Doppler brcycle erercrse PASP was Mlcutated by me IomIula 4 
. tncuspld regurgrtatmn veloclt$ + 14 mmHq (nght atnal pressure) There 
were 40 normal controls (I). and 62 pahents (II) wrth known or suspected 
plmonary hypertemton referred to our mst3ltiron tm testmg 
&surfs The 95”b contrdence mtervals (Cl) lor mean PASP were calcu- 
lated for normal ccntrols (table below) The upper llrnlt (mmHgl for normals 
was 
upper Cl IMnIl 35 0 42 1 458 4s 9 60 a 59 3 67 3 
Of the patrenls I” group II 49 had PASP at rest and at each stage .95’. C1 
seen rn normals. 8 had enercrse rnduced PASP (ExPASP) and 5 had normal 
PASP at rest and dunng exert!<: 
Conc!usron (a) Physiologic range ot PASP dunng stress IS higher Ihen 
prevrously recognrzed and provtdes a standard tar the dragnosrs 01 pulmonary 
hypertensron. (b) The prosencc ot ErPASP mnflrms that rrslrnq normal 
PASP does not exclude occult abnormalltles ot the pulmonary vosSEIS 
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Backc z!nd: We have shown lt?gt dlgltal echo IDE) IS a reliable subslltute 
